Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 382, doi. 10.1034/j.1600-0463.2003.t01-1-1110202.x
- By:
- Publication type:
- Article
Works matching IS 09034641 AND DT 2003 AND VI 111 AND IP 3
Results: 10
1
2
Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 371, doi. 10.1034/j.1600-0463.2003.t01-1-1110201.x
- By:
- Publication type:
- Article
3
Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 389, doi. 10.1034/j.1600-0463.2003.t01-1-1110203.x
- By:
- Publication type:
- Article
4
Routine genotyping of human papillomavirus samples in Denmark.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 398, doi. 10.1034/j.1600-0463.2003.t01-1-1110204.x
- By:
- Publication type:
- Article
5
Activation of the respiratory burst by Pneumocystis carinii.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 405, doi. 10.1034/j.1600-0463.2003.t01-1-1110205.x
- By:
- Publication type:
- Article
6
Myoepithelioma of the vulva.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 416, doi. 10.1034/j.1600-0463.2003.t01-1-1110206.x
- By:
- Publication type:
- Article
7
ICAM-1 and β<sub>3</sub> integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors?
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 421, doi. 10.1034/j.1600-0463.2003.t01-1-1110207.x
- By:
- Publication type:
- Article
8
Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 430, doi. 10.1034/j.1600-0463.2003.t01-1-1110208.x
- By:
- Publication type:
- Article
9
Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas.
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 439, doi. 10.1034/j.1600-0463.2003.t01-1-1110209.x
- By:
- Publication type:
- Article
10
Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
- Published in:
- APMIS, 2003, v. 111, n. 3, p. 444, doi. 10.1034/j.1600-0463.2003.t01-1-1110210.x
- By:
- Publication type:
- Article